Terms: = Pancreatic cancer AND BTK, AGMX1, 695, ENSG00000010671, XLA, IMD1, RP1-164F3_2, MGC126262, BPK, ATK, MGC126261, Q06187, AT, PSCTK1
38653 results:
1. Highly variable biological effects of statins on cancer, non-cancer, and stem cells in vitro.
Gbelcová H; Rimpelová S; Jariabková A; Macášek P; Priščáková P; Ruml T; Šáchová J; Kubovčiak J; Kolář M; Vítek L
Sci Rep; 2024 May; 14(1):11830. PubMed ID: 38782983
[TBL] [Abstract] [Full Text] [Related]
2. CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity.
Ma J; Ren D; Wang Z; Li W; Li L; Liu T; Ye Q; Lei Y; Jian Y; Ma B; Fan Y; Liu J; Gao Y; Jin X; Huang H; Li L
Sci Adv; 2024 May; 10(21):eadk8908. PubMed ID: 38781342
[TBL] [Abstract] [Full Text] [Related]
3. ULK1 Mediated Autophagy-Promoting Effects of Rutin-Loaded Chitosan Nanoparticles Contribute to the Activation of NF-κB Signaling Besides Inhibiting EMT in Hep3B Hepatoma Cells.
Wu P; Wang X; Yin M; Zhu W; Chen Z; Zhang Y; Jiang Z; Shi L; Zhu Q
Int J Nanomedicine; 2024; 19():4465-4493. PubMed ID: 38779103
[TBL] [Abstract] [Full Text] [Related]
4. The role of adjuvant transcatheter arterial chemoembolization following repeated curative resection/ablation for hepatocellular carcinoma with early recurrence: a propensity score matching analysis.
Huang K; Qian T; Chen W; Lao M; Li H; Lin WC; Chen BW; Bai X; Gao S; Ma T; Liang T
BMC Cancer; 2024 May; 24(1):620. PubMed ID: 38773564
[TBL] [Abstract] [Full Text] [Related]
5. Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.
Arias-Lorza AM; Costello JR; Hingorani SR; Von Hoff DD; Korn RL; Raghunand N
Sci Rep; 2024 May; 14(1):11570. PubMed ID: 38773189
[TBL] [Abstract] [Full Text] [Related]
6. Inside stent placement is suitable for preoperative biliary drainage in patients with perihilar cholangiocarcinoma.
Yamada R; Kuriyama N; Tanaka T; Nose K; Nakamura Y; Miwata T; Tsuboi J; Mizuno S; Nakagawa H
BMC Gastroenterol; 2024 May; 24(1):174. PubMed ID: 38769494
[TBL] [Abstract] [Full Text] [Related]
7. HHLA2 deficiency inhibits pancreatic cancer progression and THP-1 macrophage M2 polarization via EGFR/MAPK/ERK and mTOR/AKT pathway.
Zhou S; Wang Z; Zhao D; Fu Y; Zhang S; Wang Z; Zou X
World J Surg Oncol; 2024 May; 22(1):133. PubMed ID: 38762741
[TBL] [Abstract] [Full Text] [Related]
8. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract] [Full Text] [Related]
9. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.
Zheng R; Liu X; Zhang Y; Liu Y; Wang Y; Guo S; Jin X; Zhang J; Guan Y; Liu Y
Front Immunol; 2024; 15():1383978. PubMed ID: 38756774
[TBL] [Abstract] [Full Text] [Related]
10. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
[TBL] [Abstract] [Full Text] [Related]
11. Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics.
Shi X; Guo S; Duan Q; Zhang W; Gao S; Jing W; Jiang G; Kong X; Li P; Li Y; Teng C; Xu X; Chen S; Nian B; Li Z; Zhong C; Yang X; Zhu G; Du Y; Zhang D; Jin G
J Exp Clin Cancer Res; 2024 May; 43(1):145. PubMed ID: 38750539
[TBL] [Abstract] [Full Text] [Related]
12. Non-specific uptake of
Li Y; Gao J; Li Y; Duan X; Shen C
Sci Rep; 2024 May; 14(1):11141. PubMed ID: 38750103
[TBL] [Abstract] [Full Text] [Related]
13. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
[TBL] [Abstract] [Full Text] [Related]
14. Impact of heparanase-2 (Hpa2) on cancer and inflammation: Advances and paradigms.
Vlodavsky I; Hilwi M; Kayal Y; Soboh S; Ilan N
FASEB J; 2024 May; 38(10):e23670. PubMed ID: 38747803
[TBL] [Abstract] [Full Text] [Related]
15. Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
de Graaff MR; Hendriks TE; Wouters M; Nielen M; de Hingh I; Koerkamp BG; van Santvoort HC; Busch OR; den Dulk M; Klaase JM; van Zwet E; Bonsing BA; Grünhagen DJ; Besselink MG; Kok NFM
Br J Surg; 2024 May; 111(5):. PubMed ID: 38747683
[TBL] [Abstract] [Full Text] [Related]
16. Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
Yuan Y; Li S; Yan M; Yang Y; Zhong C; Hu Y
BMC Pulm Med; 2024 May; 24(1):235. PubMed ID: 38745167
[TBL] [Abstract] [Full Text] [Related]
17. The role of the size of affinity ligands in the detection and characterization of extracellular vesicles.
Pham CV; Chowdhury R; Patel S; Melke H; Hou Y; Xu H; Jia L; Duan A; Duan W; Xiang D
Biosens Bioelectron; 2024 Aug; 258():116381. PubMed ID: 38744116
[TBL] [Abstract] [Full Text] [Related]
18. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
[TBL] [Abstract] [Full Text] [Related]
19. Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma.
Kasuga R; Taniki N; Chu PS; Tamura M; Tabuchi T; Yamaguchi A; Hayatsu S; Koizumi J; Ojiro K; Hoshi H; Kaneko F; Morikawa R; Noguchi F; Yamataka K; Usui S; Ebinuma H; Itano O; Hasegawa Y; Abe Y; Kitago M; Inoue M; Nakatsuka S; Jinzaki M; Kitagawa Y; Kanai T; Nakamoto N
Sci Rep; 2024 May; 14(1):10896. PubMed ID: 38740983
[TBL] [Abstract] [Full Text] [Related]
20. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles.
Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B
Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528
[TBL] [Abstract] [Full Text] [Related]
[Next]
